Fibrinogen: a circulating factor in search of its genetic architecture.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Serum fibrinogen is not elevated in patients with myasthenia gravis.Scientific reports · 2025
   Article
2. Comparison of circulating lipid profiles, D-dimer and fibrinogen levels between hypertensive patients with and without stroke.Metabolism open · 2023
   Article
3. Novel characteristics of soluble fibrin: hypercoagulability and acceleration of blood sedimentation rate mediated by its generation of erythrocyte-linked fibers.Cell and tissue research · 2022
   Article
4. An association between fibrinogen gene polymorphisms and diabetic peripheral neuropathy in young patients with type 1 diabetes.Molecular biology reports · 2021
   Observational
5. Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals.Scientific reports · 2021
   Article
6. Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.Journal of hepatology · 2020
   Article
7. Causality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approach.Medical journal of the Islamic Republic of Iran · 2014
   Article
8. D-Dimer to Fibrinogen Ratio as a Novel Prognostic Marker in Patients After Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
   Article

Corrections and comments

• Comment on
  Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.2013

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as